Entered in highly sophisticated Injectable Segment
Expanding Research facilities
Commencement of Oncology Operations
Started Research in the area of Anti microbial Resistance (AMR)
Started Export in Overseas market
Beginning of IPR Era _ Filed patent for in-house developed Noval Antibiotic Asjuvent Entity Pproduct ELORES.
ELORES decleared as best Innovation at the DST-Lockheed Martin India Innovation Growth Program
Launched _ELORES_ for tackling global Antimicrobial Resistance (AMR) problem
Total patent grant crossed 100 mark across globe
Venus organised PAN India campaign 'AWAKE' for awareness on AMR
Colloborated with Defence Research development organization (Ministry of defence Govt of india) to provide innovative solutions for Indian Army
Unless otherwise specified, all product names appearing in this internet site are trademarks owned by or licensed to VRL India, its subsidiaries or affiliates. No use of any VRL India trademark, trade name, or trade dress in this site may be made without the prior written authorization of VRL India, except to identify the product or services of the company.